Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Poolbeg Pharma Share News (POLB)
POLB Share
Price
POLB Share
News
POLB Share
Chat4
POLB Share
Trades72
POLB
Live RNS
POLB Share
Charts
POLB Level 2
Console
POLB Live
Share Price
POLB Broker
Ratings
POLB Directors
Deals
POLB Financial
Diary
POLB
Fundamentals
POLB Short
Positions
POLB
Media
POLB Company
Research
POLB Company
Timeline
Share Price Information for Poolbeg Pharma (POLB)
Last checked at -
Last checked at 
Intraday Poolbeg Pharma Share Chart
Hookipa Pharma rules out making offer for Poolbeg Pharma
(Alliance News) - Hookipa Pharma Inc on Thursday said it is not going ahead with a bid for Poolbeg Pharma PLC.
In a brief statement regarding a possible combination between the two firms, the US-listed biopharmaceutical company said "it does not intend to make an offer for Poolbeg."
"Non-binding" and "non-exclusive" talks between the two firms were announced in early January.
Under the proposed terms announced in January, shareholders in Poolbeg, the London-based clinical stage biopharmaceutical firm, would have received 0.03 Hookipa shares for each Poolbeg share.
Shares in Poolbeg closed down 2.9% at 4.71 pence each in London on Thursday.
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Latest POLB News
- UK shareholder meetings calendar - next 7 days
2 Jun 2026 - EARNINGS & TRADING: MP Evans restarts buybacks with new programme
26 May 2026 - TRADING UPDATES: Central Asia Metals cancels share premium account
11 May 2026 - EARNINGS AND TRADING: Tullow Oil swings to annual loss as sales drop
28 Apr 2026 - TRADING UPDATES: Windar hails 'strongest ever first quarter'
15 Apr 2026 - IN BRIEF: Poolbeg Pharma celebrates Australian patent "milestone"
31 Mar 2026 - LONDON MARKET MIDDAY: Stocks and gold up, Raspberry Pi hikes FTSE 250
31 Mar 2026 - AIM WINNERS & LOSERS: Artisanal in shutdown hit; Solid State deal wins
20 Nov 2025
Related News
EARNINGS & TRADING: MP Evans restarts buybacks with new programme
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately report...
TRADING UPDATES: Central Asia Metals cancels share premium account
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Monday and not separately reported by Alliance ...
Poolbeg Pharma News
EARNINGS & TRADING: MP Evans restarts buybacks with new programme
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately report...
TRADING UPDATES: Central Asia Metals cancels share premium account
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Monday and not separately reported by Alliance ...
EARNINGS AND TRADING: Tullow Oil swings to annual loss as sales drop
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
TRADING UPDATES: Windar hails 'strongest ever first quarter'
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
IN BRIEF: Poolbeg Pharma celebrates Australian patent "milestone"
Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm focused on cancer immunotherapy - Receives formal notification of the grant fo...
LONDON MARKET MIDDAY: Stocks and gold up, Raspberry Pi hikes FTSE 250
(Alliance News) - Stock prices in London were higher at midday on Tuesday, as attacks in the US-Israel-Iran war continue alongside US President Donald...
AIM WINNERS & LOSERS: Artisanal in shutdown hit; Solid State deal wins
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.
Follow the stocks
